Advertisement

MOG-IgG-positive multifocal myelitis with intrathecal IgG synthesis as a spectrum associated with MOG autoimmunity: Two case reports

Published:September 15, 2017DOI:https://doi.org/10.1016/j.jns.2017.09.020

      Highlights

      • Two patients with multifocal myelitis who responded to immunotherapy are reported.
      • In both patients MOG antibodies were negative in serum but positive in CSF with CBA.
      • CSF should be examined for MOG antibodies in potential double seronegative NMOSD.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ramanathan S.
        • Dale R.C.
        • Brilot F.
        Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
        Autoimmun. Rev. 2016; 15: 307-324
        • Peschl P.
        • Bradl M.
        • Höftberger R.
        • Berger T.
        • Reindl M.
        Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases.
        Front. Immunol. 2017; 8: 529https://doi.org/10.3389/fimmu. 2017.00529
        • Sepúlveda M.
        • Armangue T.
        • Martinez-Hernandez E.
        • et al.
        Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
        J. Neurol. 2016; 263: 1349-1360
        • Kitley J.
        • Waters P.
        • Woodhall M.
        • et al.
        Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
        JAMA Neurol. 2014; 71: 276-283
        • Spadaro M.
        • Gerdes L.A.
        • Krumbholz M.
        • et al.
        Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis.
        Neurol. Neuroimmunol. Neuroinflammation. 2016; 3: e257https://doi.org/10.1212/NXI.0000000000000257
        • Jarius S.
        • Ruprecht K.
        • Kleiter I.
        • et al.
        MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
        J. Neuroinflammation. 2016; 13: 279
        • Titulaer M.J.
        • Höftberger R.
        • Iizuka T.
        • et al.
        Overlapping demyelinating syndromes and anti–N-methyl-d-aspartate receptor encephalitis.
        Ann. Neurol. 2014; 75: 411-428
        • Reindl M.
        • Di Pauli F.
        • Rostásy K.
        • Berger T.
        The spectrum of MOG autoantibody-associated demyelinating diseases.
        Nat. Rev. Neurol. 2013; 9: 455-461
        • Yamamoto D.
        • Uchiyama T.
        • Ohashi T.
        • Iizuka T.
        Case of steroid-responsive unilateral encephalitis with anti-myelin oligodendrocyte glycoprotein antibodies.
        Neurol. Clin. Neurosci. 2017; 5: 101-102
        • Körtvélyessy P.
        • Breu M.
        • Pawlitzki M.
        • et al.
        ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports.
        Neurol. Neuroimmunol. Neuroinflammation. 2017; 4: e335https://doi.org/10.1212/NXI.0000000000000335